FEATURED CONTENT

• AI In Clinical Trials: Key Insights From Industry Experts

  Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.

• Removing Translation Bottlenecks With AI

  See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.

   

• Rewriting The Future Of Clinical Trials

  In an increasingly data-complex environment, eCOA is emerging as a foundational pillar for both operational agility and scientific rigor in clinical development

• Agentic AI And How It's Impacting Clinical Trial Research

  Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.

• The Top 5 Myths About eCOA In 2025

  Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover the top five myths and misconceptions about eCOAs in 2025 so your clinical teams can make evidence-based decisions.

• Accelerating CRO Study Deployment At Scale

  A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.

• What Happened At ASCO 2025?

  ASCO 2025 underscored both the momentum in oncology innovation and the critical need to protect the infrastructure that enables it—ensuring that tomorrow’s breakthroughs remain within reach for all patients.

• No More Back And Forth: Building eCOAs Right The First Time

  Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.

• CRO Takes Trial Build Times From Weeks To Days

  Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.

• Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice

  Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.

• Key AI Trial Insights From Regulators And Consultants

  AI’s transformative impact promises more efficient, cost-effective, and successful clinical trials across the pharmaceutical landscape.

• Setting A New Client Standard In Study Closeout Timelines

  Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

• Building A Gold Standard Trial Experience In Japan

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence

  A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.

• Tips For Better eCOA Experiences From Medable's Patient Caregiver Network

  Hear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.

• GSK And Medable Discuss The Next Phase Of DCTs

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

• Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan

  A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.

• Leveraging eCOA To Improve Patient Adherence In Clinical Trials

  Patient adherence is one of the biggest challenges in clinical trials. eCOA solutions offer intuitive and engaging tools that encourage participants to complete their assessments on time.

• The Evidence And Outcomes Of Decentralized Modalities

  As trials continue to digitize, learn how connected sensors, COAs, and other data practices will come together to form the evidence of tomorrow—with proven, real-life examples.

• Solving Key eCOA Challenges Through Digital Trials—Proof Points!

  Medable has reached some important milestones and shares them in its end-of-year report. Check it out to see what game-changing results they've brought to their customers.